Specimen

Part LP7593-9SYSTEM

125 tests use this part (showing first 100)

LOINCName
100154-4 Specimen collection supervision level
100969-5 Pathology report additional specified observation in Specimen Narrative
102034-6 Pathology report microscopic observation in Specimen
105012-9 Fungal ITS region in Specimen (qualitative, sequencing)
106430-2 Clostridium botulinum toxin in Specimen (endopep-ms)
106578-8 Monkeypox virus clade Ia DNA in Specimen (qualitative, naa with probe detection)
106579-6 Monkeypox virus clade Ib DNA in Specimen (qualitative, naa with probe detection)
106615-8 Monkeypox virus DNA in Specimen (naa with probe detection)
21893-3 Regional lymph nodes positive Specimen
21894-1 Regional lymph nodes examined Specimen
22633-2 Pathology report site of origin Narrative
22634-0 Pathology report gross observation Narrative
22635-7 Pathology report microscopic observation Narrative Other stain
22636-5 Pathology report relevant history Narrative
22637-3 Pathology report final diagnosis Narrative
22638-1 Pathology report comments Narrative
22639-9 Pathology report supplemental reports Narrative
22640-7 Pathology report staging evidence Narrative
24419-4 Pathology report gross observation
33722-0 CAP cancer protocols Collection method
33723-8 Specimen length
33724-6 Collection method -
33725-3 Tumor site
33726-1 Macroscopic tumor configuration
33727-9 Macroscopic tumor configuration (cap cancer protocols)
33733-7 Sites of distant metastasis
33734-5 Surgical margin tumor involvement.proximal (cap cancer protocols)
33735-2 Surgical margin tumor involvement.distant (cap cancer protocols)
33736-0 Surgical margin tumor involvement.circumferential (cap cancer protocols)
33737-8 Distance of tumor from closest margin
33738-6 Closest margin
33739-4 Lymphatic.small vessel.invasion in Specimen (cap cancer protocols)
33740-2 Venous.large vessel.invasion in Specimen (cap cancer protocols)
33741-0 Perineural invasion in Specimen (cap cancer protocols)
33742-8 Tumor border configuration in Specimen
33743-6 Intratumoral /Peritumoral lymphocytic response (cap cancer protocols)
33744-4 Additional pathological findings (cap cancer protocols)
33745-1 Polyps in Specimen Narrative
33746-9 Pathologic findings
33747-7 Number of fragmented pieces
33748-5 Distance from anal verge
33749-3 Distance from anal verge unknown (cap cancer protocols)
33750-1 Margins cannot be assessed (cap cancer protocols)
33751-9 Surgical margin tumor involvement.lateral in Specimen (cap cancer protocols)
33752-7 Distance of carcinoma from closest lateral margin in Specimen
33753-5 Lateral margin location (cap cancer protocols)
33754-3 Surgical margin tumor involvement.deep in Specimen (cap cancer protocols narrative)
33755-0 Distance of carcinoma from deep margin in Specimen
33756-8 Polyp size greatest dimension
33757-6 Polyp size additional dimensions
33758-4 Polyp stalk length (cap cancer protocols)
33759-2 Deepest extent of invasion in Specimen (qualitative)
33760-0 Surgical margin tumor involvement.mucosal in Specimen (cap cancer protocols)
33761-8 Venous + Lymphatic small vessel invasion in Specimen (cap cancer protocols)
34574-4 Pathology report final diagnosis
35265-8 Pathology report addendum in Specimen Narrative
35266-6 Gleason score in Specimen Qualitative (qualitative)
35660-0 Pathology report final diagnosis section - text
44618-7 Total linear mm of carcinoma
44619-5 Length core(s) (Tissue)
44620-3 Other quantitation (cap cancer protocols)
44621-1 Regional lymph nodes examined (cap cancer protocols)
44622-9 Regional lymph nodes containing metastases (cap cancer protocols)
44623-7 Matted nodes (cap cancer protocols)
44625-2 Periprostatic fat invasion in Specimen (cap cancer protocols)
44626-0 Seminal vesicle invasion in Specimen (cap cancer protocols)
53903-1 Collection method - Specimen
63572-2 Time received in laboratory of Specimen
66746-9 Specimen type
68992-7 Specimen-related information panel
73703-1 Pathology report preliminary diagnosis in Specimen
74384-9 Specimen container
80581-2 Specimen incubation date and time range
81170-3 Greater curvature of stomach in Specimen
81171-1 Lesser curvature of stomach in Specimen
81172-9 Esophagus in Specimen
81173-7 Duodenum in Specimen
81175-2 Distance of tumor from closest margin in Specimen (macroscopy)
81176-0 Distance of tumor from circumferential resection margin in Specimen (macroscopy)
81178-6 Tissue block description and site Narrative
81182-8 Distance of tumor from closest proximal margin in Specimen (light microscopy)
81183-6 Distance of tumor from closest distal margin in Specimen (light microscopy)
81184-4 Distance of tumor from circumferential resection margin (microscopy)
81185-1 Non-regional lymph nodes positive in Specimen
81187-7 Non-regional lymph nodes examined in Specimen
81317-0 Additional pathological findings in Specimen
81744-5 Submitter's laboratory test method in Specimen
82314-6 Specimen sent to CDC (qualitative)
83321-0 Pathology report intraoperative observation in Specimen Document
84881-2 Polyps in Specimen (qualitative)
84894-5 Dimension of Specimen
84895-2 Seminal vesicles in Specimen (qualitative)
84896-0 Lymph node(s) in Specimen (qualitative)
85069-3 Lab test method
85298-8 Body structure included in specimen in Specimen
85341-6 Pathology report reviewed in Specimen
85346-5 Tissue blocks examined in Specimen
85348-1 Procedure used to obtain tumor specimen in Specimen
86952-9 Preliminary testing done Specimen (qualitative)
86953-7 Preliminary testing result Specimen